ArticleInternational journal of surgery (London, England)2026
Deep learning for prognostic stratification and biomarker exploration in upper tract urothelial carcinoma: a multicenter retrospective cohort study.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation of an interpretable machine learning model for predicting 5-year recurrence in breast cancer.Frontiers in medicine · 2026Article
- Radiomics and deep learning in upper tract urothelial carcinoma: advancing preoperative risk stratification and clinical decision-making.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUpper tract urothelial carcinoma (UTUC) necessitates precise prognostic assessment for personalized therapy due to its aggressive nature and the limitations of traditional methods. An objective, interpretable pathological evaluation system is urgently needed to improve UTUC risk stratification and patient outcomes.
methodsIn this multicenter retrospective study, we developed a prior knowledge-guided deep learning system using whole-slide images from 805 UTUC patients who underwent radical nephroureterectomy. The UCSegNet tile classifier was employed for eight-category tissue segmentation, and the CONCH vision-language model was used for tumor patch categorization, creating integrated probability heatmaps. Two prognostic networks, MacroContextNet and PGCA-Net, were then trained to predict the overall survival (OS) by integrating these multiscale pathological features. AI-derived quantitative pathological biomarkers were explored, including tissue fraction scores and co-localization scores. Model performance was evaluated using the concordance index (C-index), time-dependent area under the receiver operating characteristic curve (AUC), and multivariable Cox regression.
resultsThe UCSegNet tile classifier achieved excellent multiclass tissue classification accuracy across all cohorts (AUC range: 0.9916-0.9948). The primary prognostic model, PGCA-Net, demonstrated superior prognostic performance (C-index range: 0.672-0.795 across validation cohorts) compared to MacroContextNet (C-index range: 0.643-0.730) and outperformed current state-of-the-art models. After adjustment for clinical covariates, PGCA-Net effectively stratified patients into high-risk and low-risk groups for OS, with hazard ratios (HRs) for the high-risk group ranging from 4.93 to 9.38 across different cohorts. Seven AI-derived quantitative pathological biomarkers were identified and validated; notably, high tumor-muscle co-localization (Coloc_M) scores (HR up to 5.06) and high tumor-renal parenchyma co-localization (Coloc_R) scores (HR up to 4.52) consistently predicted increased mortality risk.
conclusionsThis prior knowledge-guided deep learning system significantly improves OS prediction and risk stratification in UTUC by integrating multiscale pathological features. The AI-driven, interpretable tool offers an objective approach for prognostic assessment and biomarker discovery, with strong potential to refine personalized UTUC management and enhance prognostic accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.